Navigation Links
Genta Receives Notice of Non-Compliance with Listing Requirement for NASDAQ Global Market
Date:11/16/2007

the Company's Annual Report

on Form 10-K and Quarterly Report on Form 10-Q.

The Company does not undertake to update any forward-looking statements. There are a number of factors that could cause actual results and developments to differ materially. For a discussion of those risks and uncertainties, please see the Company's Annual Report on Form 10-K for 2006 and its most recent quarterly report on Form 10-Q.

CONTACT:

Nichol Harber

Genta Investor Relations

info@genta.com

Brian Korb

The Trout Group

908-286-3980


'/>"/>
SOURCE Genta Incorporated
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related biology technology :

1. Genta Announces Presentation of New Clinical and Preclinical Data on Genasense(R) at AACR-NCI-EORTC Targets Conference
2. Syngenta Licenses Chromatin Gene Stacking Technology
3. Genta Completes Appeal of FDA Decision for Genasense(R) in CLL
4. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
5. Ciphergen Biosystems Receives Noncompliance Letter From The Nasdaq Stock Market
6. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
7. Anesiva Receives FDA Approval for Zingo(TM), a New, Innovative Product to Reduce Pain Associated with Needle Insertion Procedures in Children
8. IsoTis Receives FDA Clearance for Accell Family of Products
9. Actavis Receives Approval of Fentanyl Transdermal System in the U.S.
10. AGA Medical Corporation Receives FDA and CE Mark Approvals for the AMPLATZER Vascular Plug II
11. IDM Pharma Receives Not Approvable Letter for Mifamurtide (L-MTP-PE) for the Treatment of Osteosarcoma

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009).../ - Aegera Therapeutics Inc. announced today the d...B study of AEG35156, a targeted antisense therapeu... indications. ,, The study, entitled "An Open-L...bitor of Apoptosis (XIAP) Antisense AEG35156 Given...ubicin in AML Following Failure of a Single Standa...
(Date:11/19/2009)...ne Synthesis Companies Form International Gene Syn...ces in Risk Reduction ,Five Member Companies Rep...city , (PRWEB) November 1...synthesis companies today announced agreement that...omote biosecurity in the gene synthesis industry. ...
(Date:11/19/2009)...mber 19 AFFiRiS AG will focus its,...te at an unexpectedly early,stage of development: ...o,Phase II clinical trial early in 2010. This deci...tion of two Phase I trials with the candidates,AD0... the first interim,analysis of the secondary endpo...
(Date:11/18/2009)... Standards and Technology (NIST) has demonstrated ...ing and measuring elusive hazards such as conceale...d or pesticides distributed in soil by wind and ra...nventional techniques for detecting traces of thes...having distinct electrically positive and negative...
Breaking Biology Technology:Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the Treatment of Acute Myeloid Leukemia (AML) 2World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 2World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 3World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 4AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 2AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 3Prototype NIST method detects and measures elusive hazards 2
...ader in,at-home diagnostic sleep testing and sleep...ved version of its main web site,( http://www.slee...ity of,patients, family members, and healthcare pr... sleep testing and sleep apnea,treatment, we have ...xpanding patient population," said Robert Koenigsb...
.... (Nasdaq: BFRM ) today announced that Steven Bas...y overview at the upcoming 26th Annual,JPMorgan He...2008. BioForm,Medical,s presentation will take pla...11:30 am EST) at the Westin St. Francis Hotel in S... webcast of BioForm Medical,s,presentation will be...
...earlier treatment could ...ntists working at the,Hepatitis B Foundation, in p...ine, think they may have discovered a reliable alt...f liver fibrosis and cirrhosis, which,afflict more... and C,infections, as well as fatty liver diseases...
Other Biology Technology:SleepQuest Launches Updated Web Site 2BioForm Medical to Present at the 2008 JPMorgan Healthcare Conference on January 7, 2008 2Possible New Way to Detect, Monitor Liver Disease Without Painful Liver Biopsy 2
(Date:11/20/2009)...s., November 19, 2009 The estimated 4.6 million A... risk of developing respiratory symptoms due to po...tionnaire study undertaken earlier this year by in...of Veterinary Medicine. , The studywhich polled ...hat 50 percent of individuals working in barns com...
(Date:11/20/2009)...vailable in German . , In the current onlin..., Dr. Stefanie Eyerich and Dr. Kilian Eyerich toge...ondon and Istituto Dermopatico dell,Immacolata in ...epresents a milestone on the way to developing new...such as psoriasis and allergic reactions and poten...
(Date:11/20/2009)...n a new study, researchers report that a class of ...helpful, or harmful, effect on the heart, dependin...h appears in the journal Circulation Research , f...- and beta-receptors on the heart muscle offer the...t target only the beta-receptors can actually unde...
Breaking Biology News(10 mins):Barn personnel experience higher-than-average rates of respiratory symptoms 2Discovery of new type of immune cells regulating inflammation in chronic diseases 2Carvedilol shown to have unique characteristics among beta blockers 2Any Day OK for Heart Bypass Surgery 58127 1Any Day OK for Heart Bypass Surgery 58127 2University of Hawaii Maui Community College Selects American TeleCare for Allied Health Department 26apos 3Bs Nursing Telehealth Project 58122 1University of Hawaii Maui Community College Selects American TeleCare for Allied Health Department 26apos 3Bs Nursing Telehealth Project 58122 2University of Hawaii Maui Community College Selects American TeleCare for Allied Health Department 26apos 3Bs Nursing Telehealth Project 58122 3PAREXEL Consulting Releases New Study Data on Drug Development Timelines in Safety First Era 14223 1PAREXEL Consulting Releases New Study Data on Drug Development Timelines in Safety First Era 14223 2PAREXEL Consulting Releases New Study Data on Drug Development Timelines in Safety First Era 14223 3PAREXEL Consulting Releases New Study Data on Drug Development Timelines in Safety First Era 14223 4PAREXEL Consulting Releases New Study Data on Drug Development Timelines in Safety First Era 14223 5
... The definition of conservation priorities for bi...rtebrate animals and seed plants in the northern h...ther organisms, and the more extreme regions of th...lants and mammals is low" An interdisciplinary tea...nd philosophers explored the worlds southernmost f...
... Washington, D.C. October 24, 2007 - The U.S. Se...d Education Appropriations Bill (S.1710), includin... of Health (NIH) to strengthen its Public Access P...ation by researchers. The bill will now be reconci...ains a similar provision, in another step toward s...
... WORCESTER, Mass. As the HIV/AIDS epidemic conti... million lives and infecting over 39 million, rese...roved treatments for those suffering with this dis...ng 15 to 59 year olds, AIDS is a remarkably resili...pidly. This evolution dramatically complicates tre...
Other Biology News:The conservation lens 2The conservation lens 3Mandate for public access to NIH-funded research poised to become law 2UMass Medical School researchers receive $8.5M grant award to fight AIDS 2UMass Medical School researchers receive $8.5M grant award to fight AIDS 3
Eosinophil Chip-IHC from 3H Biomedical AB
B Cell Chip-IHC from 3H Biomedical AB
Basophil Chip-IHC from 3H Biomedical AB
UCB CD4 T Cell Chip-IHC from 3H Biomedical AB
Biology Products: